Background: A palliative care approach, as used routinely in cancer, is also valid for incurable chronic illnesses such as chronic obstructive airways disease (COPD). However, a London study recently reported that general practitioners (GPs), who provide most end-stage care for COPD patients, do not routinely discuss prognosis with these patients.

Objective: To compare the views of GPs in Auckland, New Zealand (NZ) and London, United Kingdom (UK) on discussions of prognosis in severe COPD.

Method: A postal questionnaire of 509 randomly selected Auckland GPs. The questionnaire was almost identical to the UK one. Comparisons were made with aggregated statistics for the London sample as reported in published findings and personal communication with the London authors.

Results: The Auckland response rate of 56% was similar to that of the London study (55%). Most GPs in both samples stated that discussions on prognosis are necessary in severe COPD and that GPs have an important role in discussing prognosis. Smaller proportions of both samples reported usually having such discussions, although Auckland GPs (55.6%) were more likely to hold the discussions than were London counterparts (40.7%). Auckland GPs were also more likely to agree that patients with severe COPD want to discuss prognosis and that patients value these discussions. One-third of the Auckland GPs and nearly half the London GPs believe that some patients with severe COPD who want to discuss prognosis are not given the opportunity to do so.

Conclusion: Auckland GPs are more open than their London counterparts to discussing prognosis in severe COPD. There is increased scope for GPs in London to discuss prognosis with these patients. Further support is needed for GPs in both countries who do not routinely discuss prognosis in severe COPD, but consider it is necessary to have these discussions.

Download full-text PDF

Source
http://dx.doi.org/10.1093/fampra/cmi052DOI Listing

Publication Analysis

Top Keywords

severe copd
24
prognosis severe
20
discuss prognosis
20
auckland gps
20
discussing prognosis
12
gps
12
prognosis
10
london
10
copd
8
auckland
8

Similar Publications

Chronic Obstructive Pulmonary Disease: Lifestyle Impact.

Int J Prev Med

November 2024

Department of Nutrition and Dietetics, School of Allied Health Sciences, Faridabad, Haryana, India.

Article Synopsis
  • Respiratory infections are a major global health issue, responsible for 7.5 million deaths annually, highlighting their impact on both health and economics.
  • Chronic obstructive pulmonary disease (COPD) arises from lifestyle choices and environmental factors, necessitating interventions like smoking cessation, healthy diets, and physical activity to improve lung health.
  • European health initiatives focus on early detection and prevention through awareness campaigns, vaccination programs, and nutritional support to reduce the incidence and severity of respiratory diseases.
View Article and Find Full Text PDF

Comparison of STAR and GOLD in Assessing Disease Severity Among High-Risk and COPD Patients: Evidence from Enjoying Breathing Program in China.

Int J Chron Obstruct Pulmon Dis

January 2025

Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China; National Center for Respiratory Medicine, Beijing, China; State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, People's Republic of China.

Background: The STAR staging standard has been demonstrated to have good performance in distinguishing mortality among patients at different stages. However, the effectiveness of STAR and GOLD staging in distinguishing disease severity in high-risk and COPD patients remained unclear.

Methods: Based on Enjoying Breathing Program data through June 2023, a total of 7.

View Article and Find Full Text PDF

Introduction: Chronic obstructive pulmonary disease (COPD) is a disease with severe therapeutic obstacles and high worldwide death rate. COPD progresses predominantly through inflammatory response followed by fibrotic destruction. Quercetin (Que), recognized for its anti-inflammatory effects, presents significant promise as a therapeutic candidate for COPD therapy.

View Article and Find Full Text PDF

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus (RSV) are highly infectious respiratory viruses that affect people of all ages and are typically associated with mild symptoms and few complications in immunocompetent individuals. However, the risk of severe outcomes (e.g.

View Article and Find Full Text PDF

Background And Objectives: Airway fungal infection is a severe clinical problem, especially in patients with compromised immune functions. Here, we examined the distribution and antifungal susceptibility profiles of fungal agents isolated from respiratory tract of symptomatic patients hospitalized in pulmonary units.

Materials And Methods: This descriptive cross-sectional study took place from 2023 to 2024, involving 360 patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!